Pharmacy Times
JULY 9, 2024
In a new report, the FTC says pharmacy benefit managers act as middlemen in the pharmaceutical industry, leading to the squeezing of independent pharmacies and increases in prices for patients.
Drug Topics
JULY 10, 2024
A former sergeant first class in the US Army discussed PTSD in an exclusive interview with Drug Topics.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PharmaVoice
JULY 9, 2024
Vetigenics believes it’s found a way to make pricey antibody-based technologies more accessible for animals.
STAT
JULY 11, 2024
Alcohol has long been classified as a cancer-causing substance, but a study out Thursday gives a clearer sense of just how many cancer cases and deaths may be driven by drinking. Researchers from the American Cancer Society and International Agency for Research on Cancer estimate 40% of all cancer cases in the United States in people 30 and up were due to “potentially modifiable risk factors,” including cigarette smoking, physical inactivity, consumption of processed meat, vi
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmacy Times
JULY 11, 2024
In a follow-up to the interim FTC report documenting the business practices of PBMs and the power they hold in the pharmaceutical industry, the Commission now seeks to sue the 3 largest PBMs in the country for driving up the price of insulin and other essential drugs.
Drug Topics
JULY 12, 2024
Global coverage for diphtheria, tetanus, and pertussis has reached its lowest point in 15 years.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
JULY 11, 2024
A key part of the federal government’s narrative about the epidemic of addiction and overdose deaths in the U.S. has been that it is driven by doctors and other clinicians overprescribing opioid painkillers. That story line is false — and was never true. The Centers for Disease Control and Prevention has traditionally relied on death certificate data compiled by the National Center for Health Statistics for its data on overdose deaths, organized as Underlying Cause of Death data us
Pharmacy Times
JULY 12, 2024
Helping patients overcome barriers to accessing these treatments is a vital role for pharmacists, who can support patients who are looking to quit.
Drug Topics
JULY 8, 2024
Researchers addressed the association between semaglutide use and the risk of nonarteritic anterior ischemic optic neuropathy.
PharmaVoice
JULY 10, 2024
The company has begun searching for a successor to Dolsten, who oversaw more than 35 drug and vaccine approvals alongside notable setbacks during his time as Pfizer’s top scientist.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
JULY 11, 2024
As Covid-19 swept across the United States, schools were among the most highly affected public spaces. To prepare for a potential H5N1 avian influenza jump to humans, schools need to be preparing for the scenario now before a sustained transmission event occurs. The response to Covid-19, which first appeared in the U.S. in early 2020, has been scrutinized by numerous case studies, after-action reports , and Congressional fact-finding hearings.
Pharmacy Times
JULY 9, 2024
Daily multivitamin users were associated with a 4% higher mortality risk compared to nonusers.
Drug Topics
JULY 9, 2024
Researchers are evaluating the safety, tolerability, and immunogenicity of shingles vaccine candidate Z-1018.
PharmaVoice
JULY 8, 2024
The long-awaited guidance offers a more detailed road map for pharma.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
JULY 11, 2024
WASHINGTON – They’re marketed as healthy, “dietitian-approved” meals and delivered directly to the homes of people seriously ill from cancer, diabetes, or heart disease: a Jimmy Dean frozen sausage breakfast sandwich, biscuits and gravy, a cheeseburger. These are among the offerings sold by an Idaho-based company, Homestyle Direct, which is paid millions of dollars each year by taxpayer-funded state Medicaid programs to deliver what the company calls medically tailore
Pharmacy Times
JULY 12, 2024
Results show that daily injections of buprenorphine over a 7-day period was safe and well-tolerated in patients who had Clinical Opioid Withdrawal Scale scores of 4 to 7.
Drug Topics
JULY 8, 2024
Current recommendations suggest women receive the RSV vaccine between 32 and 36 weeks' gestational age.
Fierce Healthcare
JULY 8, 2024
U.S. digital health startups pulled in $5.7 billion across 266 deals in the first six months of 2024, marking continued momentum in the sector after a rocky few quarters last year. | U.S. digital health startups pulled in $5.7 billion across 266 deals in the first six months of 2024, marking continued momentum in the sector after a rocky few quarters last year.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
JULY 11, 2024
WASHINGTON — When Elmo asked “How is everybody doing?” back in January, he was not expecting the onslaught of stress, despair, and anxiety that hit his replies. “I’m just looking for somebody to talk to and show me some love if you know what I mean,” famous singer T-Pain wrote back to the red Muppet.
Pharmacy Times
JULY 12, 2024
Unique gut flora were found in children with autism spectrum disorder (ASD).
Drug Topics
JULY 8, 2024
When used together, sodium glucose co-transporter 2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) were able to lower the risk of major adverse cardiovascular events and kidney disease by 11% and 33%, respectively.
Fierce Healthcare
JULY 9, 2024
OpenAI's venture fund and Arianna Huffington's Thrive Global are backing a new startup, Thrive AI Health, that aims to build an AI health coach to promote healthier lifestyles. | OpenAI's venture fund and Arianna Huffington's Thrive Global are backing a new startup that aims to build an AI health coach to promote healthier lifestyles.
STAT
JULY 9, 2024
STAT is co-publishing this investigation by Undark. They numbered 20 in all — 10 men and 10 women who came to a sprawling medical campus in downtown Buffalo, N.Y., to volunteer for what a news report had billed as “the world’s biggest science project.
Pharmacy Times
JULY 11, 2024
Previous studies have shown that individuals living with HIV are at higher risk for heart disease than individuals without HIV
Drug Topics
JULY 12, 2024
Researchers aimed to address the extent of stigmatization’s effect on the mental health of adolescents with chronic skin disorders.
PharmaVoice
JULY 11, 2024
Drugmakers pointed the finger at PBMs for being the culprit behind rising drug prices in the U.S. for years — now, an ongoing FTC investigation has their back.
STAT
JULY 9, 2024
In stark terms, the Federal Trade Commission found in a report released Tuesday that pharmacy benefit managers — the opaque middlemen in the pharmaceutical supply chain — wield such “enormous power” that these companies can affect the ability of many Americans to access and afford their medicines. The agency noted that the three largest PBMs processed nearly 80% of the roughly 6.6 billion prescriptions dispensed by U.S. pharmacies in 2023.
Pharmacy Times
JULY 11, 2024
Prevalence of dry eye is increasing drastically, especially in younger individuals, because of the current lifestyle and increased technology use.
Drug Topics
JULY 11, 2024
“They may not understand. But I tell people, ‘I don't want you to understand me.’ I don't understand me. But if you can relate to me, then that furthers our conversation—the relatedness,” said Farron Dozier on his experience with PTSD.
PharmaVoice
JULY 10, 2024
As more Americans take obesity medications, adjacent businesses are offering supportive services to offset side effects, collect data and foster new health benefits.
STAT
JULY 10, 2024
The U.S. Federal Trade Commission plans to sue the three largest pharmacy benefit managers over their negotiating tactics for various medicines, including insulin, that pushed patients toward higher-priced treatments, according to a source familiar with the matter. The step comes after the agency this week released a scathing report that found the three largest PBMs — Express Scripts, Caremark, and OptumRx — processed nearly 80% of the roughly 6.6 billion prescriptions that were di
Pharmacy Times
JULY 11, 2024
Intravenous immunoglobulin was effective as an adjunctive treatment to anticoagulation in a patient with post-viral platelet-activating anti-PF4 disorder, indicating the need for accurate diagnosis and treatment selection.
Drug Topics
JULY 9, 2024
Previously, data from head-to-head trials of tirzepatide and semaglutide were not available.
Expert insights. Personalized for you.
149 
Let's personalize your content